- Home
- FTI vs WAT Comparison
FTI vs WAT Comparison
Compare FTI & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- WAT
- Stock Information
- Founded
- FTI 1884
- WAT 1958
- Country
- FTI United States
- WAT United States
- Employees
- FTI N/A
- WAT N/A
- Industry
- FTI Metal Fabrications
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- FTI Industrials
- WAT Industrials
- Exchange
- FTI Nasdaq
- WAT Nasdaq
- Market Cap
- FTI 16.4B
- WAT 17.4B
- IPO Year
- FTI N/A
- WAT 1995
- Fundamental
- Price
- FTI $37.47
- WAT $328.97
- Analyst Decision
- FTI Strong Buy
- WAT Hold
- Analyst Count
- FTI 14
- WAT 13
- Target Price
- FTI $39.75
- WAT $375.54
- AVG Volume (30 Days)
- FTI 7.7M
- WAT 705.5K
- Earning Date
- FTI 10-23-2025
- WAT 11-04-2025
- Dividend Yield
- FTI 0.52%
- WAT N/A
- EPS Growth
- FTI 115.07
- WAT 10.77
- EPS
- FTI 2.17
- WAT 11.09
- Revenue
- FTI $9,504,100,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- FTI $9.81
- WAT $7.15
- Revenue Next Year
- FTI $7.58
- WAT $6.34
- P/E Ratio
- FTI $17.62
- WAT $28.75
- Revenue Growth
- FTI 11.75
- WAT 5.89
- 52 Week Low
- FTI $22.12
- WAT $275.05
- 52 Week High
- FTI $41.30
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- FTI 44.01
- WAT 59.89
- Support Level
- FTI $37.38
- WAT $319.34
- Resistance Level
- FTI $38.89
- WAT $331.28
- Average True Range (ATR)
- FTI 0.97
- WAT 8.73
- MACD
- FTI -0.35
- WAT 2.77
- Stochastic Oscillator
- FTI 14.51
- WAT 74.94
About FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.